At just 19 months old, Gunner’s strength, smile and love of ducks are helping shine a light on cystic fibrosis.

In a small study, CF patients treated with the therapy saw a reduction in multidrug-resistant lung bacteria and improved lung ...

Conference Call and Webcast Information Verona Pharma will host a live webcast and a conference call at 9:00 a.m. EDT / 2:00 p.m. BST on Tuesday, April 29, 2025, to discuss the first quarter 2025 ...

Total net revenue of $76.3 million from Q1 2025 driven by Ohtuvayre® net sales of $71.3 million (+95% vs Q4 2024) ~25,000 prescriptions filled in Q1 2025 Q1 2025 revenue exceeds operating expenses exc ...

Scientists have discovered that the same device used to measure C-reactive protein (CRP) in blood to diagnose bacterial ...

New guidelines for cystic fibrosis screening in newborns improve sensitivity, equity, and timeliness of diagnosis.

People with diseases caused by rare mutations have fewer options and poorer prospects than other patients despite rapid ...

for the treatment of people with cystic fibrosis (CF) ages 6 years and older who have at least one non-class I mutation in the cystic fibrosis transmembrane conductance regulator (CFTR ...

The outcomes of patients with idiopathic pulmonary fibrosis (IPF) remain unknown. Alongside the global adoption of antifibrotic therapies, there is currently relentless research for biomarkers and ...

Battling a rare mutation of cystic fibrosis, Emily Kramer-Golinkoff fights for her life — and for gene therapies that offer ...

Sionna Therapeutics has closed its initial public offering, raising $191 million for its pipeline of therapies for cystic fibrosis (CF ... which provides a treatment option for up to 90% of ...